Journal Information

Statistics

Follow this link to access the full text of the article

Original Article
Clinical and economic consequences of using dabigatran or rivaroxaban in patients with non-valvular atrial fibrillation
Consequências clínicas e económicas da utilização de dabigatrano e de rivaroxabano em doentes com fibrilhação auricular não valvular
Luís Silva Miguela,
Corresponding author
luissm@cisep.iseg.ulisboa.pt

Corresponding author.
, Jorge Ferreirab
a Centro de Investigação Sobre Economia Portuguesa, Instituto Superior de Economia e Gestão, Universidade de Lisboa, Lisboa, Portugal
b Serviço de Cardiologia, Hospital de Santa Cruz, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal
Read
6450
Times
was read the article
1705
Total PDF
4745
Total HTML
Share statistics
Article information
ISSN: 21742049
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 December 29 9 38
2024 November 41 31 72
2024 October 31 26 57
2024 September 48 19 67
2024 August 48 25 73
2024 July 34 23 57
2024 June 30 26 56
2024 May 29 23 52
2024 April 29 23 52
2024 March 35 23 58
2024 February 23 19 42
2024 January 26 25 51
2023 December 18 25 43
2023 November 32 23 55
2023 October 28 15 43
2023 September 17 21 38
2023 August 32 16 48
2023 July 34 13 47
2023 June 27 8 35
2023 May 44 25 69
2023 April 30 2 32
2023 March 35 17 52
2023 February 44 25 69
2023 January 16 6 22
2022 December 41 23 64
2022 November 43 23 66
2022 October 23 18 41
2022 September 22 27 49
2022 August 24 21 45
2022 July 25 26 51
2022 June 17 23 40
2022 May 19 31 50
2022 April 24 23 47
2022 March 23 23 46
2022 February 19 21 40
2022 January 18 18 36
2021 December 13 26 39
2021 November 36 30 66
2021 October 29 32 61
2021 September 22 26 48
2021 August 26 24 50
2021 July 17 27 44
2021 June 24 15 39
2021 May 21 29 50
2021 April 51 28 79
2021 March 70 22 92
2021 February 53 19 72
2021 January 31 18 49
2020 December 32 9 41
2020 November 35 16 51
2020 October 22 16 38
2020 September 49 12 61
2020 August 25 6 31
2020 July 54 18 72
2020 June 32 8 40
2020 May 36 5 41
2020 April 54 18 72
2020 March 48 12 60
2020 February 129 32 161
2020 January 27 4 31
2019 December 31 8 39
2019 November 39 11 50
2019 October 36 7 43
2019 September 23 8 31
2019 August 47 10 57
2019 July 34 10 44
2019 June 30 16 46
2019 May 38 7 45
2019 April 25 13 38
2019 March 101 12 113
2019 February 126 9 135
2019 January 87 8 95
2018 December 90 11 101
2018 November 192 16 208
2018 October 536 11 547
2018 September 154 12 166
2018 August 43 12 55
2018 July 20 5 25
2018 June 30 7 37
2018 May 45 9 54
2018 April 41 9 50
2018 March 45 14 59
2018 February 23 7 30
2018 January 26 4 30
2017 December 52 12 64
2017 November 45 12 57
2017 October 39 7 46
2017 September 33 16 49
2017 August 35 10 45
2017 July 27 10 37
2017 June 46 8 54
2017 May 44 10 54
2017 April 28 6 34
2017 March 52 5 57
2017 February 41 6 47
2017 January 34 4 38
2016 December 52 18 70
2016 November 38 16 54
2016 October 46 12 58
2016 September 36 9 45
2016 August 10 0 10
2016 July 26 9 35
2016 June 15 29 44
2016 May 11 15 26
2016 April 60 1 61
2016 March 119 57 176
Show all

Follow this link to access the full text of the article

Idiomas
Revista Portuguesa de Cardiologia (English edition)
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

By checking that you are a health professional, you are stating that you are aware and accept that the Portuguese Journal of Cardiology (RPC) is the Data Controller that processes the personal information of users of its website, with its registered office at Campo Grande, n.º 28, 13.º, 1700-093 Lisbon, telephone 217 970 685 and 217 817 630, fax 217 931 095, and email revista@spc.pt. I declare for all purposes that the information provided herein is accurate and correct.